These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23739515)

  • 1. [An electromyographic study on the development of optimal tactics of botulinum toxin type A injections in children with spastic forms of cerebral palsy].
    Kurenkov AL; Kuzenkova LM; Burgasova BI; Petrova SA; Klochkova OA; Nikitin SS; Artemenko AR; Mamed'iarov AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5 Pt 2):53-60. PubMed ID: 23739515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
    El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
    J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Instrumented assessment of the effect of Botulinum Toxin-A in the medial hamstrings in children with cerebral palsy.
    Bar-On L; Aertbeliën E; Molenaers G; Van Campenhout A; Vandendoorent B; Nieuwenhuys A; Jaspers E; Hunaerts C; Desloovere K
    Gait Posture; 2014 Jan; 39(1):17-22. PubMed ID: 23791154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
    Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
    Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
    Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
    Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
    Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of motor end plate-targeted Botulinum toxin type A injections in children with cerebral palsyitle.
    Van Campenhout A; Bar-On L; Desloovere K; Molenaers G
    Acta Orthop Belg; 2015 Jun; 81(2):167-71. PubMed ID: 26280952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.
    Schless SH; Cenni F; Bar-On L; Hanssen B; Kalkman B; O'brien T; Aertbeliën E; Van Campenhout A; Molenaers G; Desloovere K
    Dev Med Child Neurol; 2019 Jul; 61(7):783-790. PubMed ID: 30320442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
    Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
    Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
    Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
    Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
    Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Foot deformity in children with spastic forms of cerebral palsy: the treatment with botulinum toxin type A (dysport)].
    Kurenkova AL; Dutikova EM; Nikitin SS; Artemenko AR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):37-43. PubMed ID: 20559272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy.
    Placzek R; Siebold D; Funk JF
    Toxins (Basel); 2010 Sep; 2(9):2258-71. PubMed ID: 22069684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of leg muscle botulinum toxin A injections on walking in children with spasticity-related cerebral palsy: a systematic review.
    Ryll U; Bastiaenen C; De Bie R; Staal B
    Dev Med Child Neurol; 2011 Mar; 53(3):210-6. PubMed ID: 21291464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
    Büyükavcı R; Büyükavcı MA
    Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.
    Kawano A; Yanagizono T; Kadouchi I; Umezaki T; Chosa E
    J Orthop Sci; 2018 Mar; 23(2):389-393. PubMed ID: 29146092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of botulinum toxin type A injection into the gastrocnemius muscle on sit-to-stand transfer in children with spastic diplegic cerebral palsy.
    Park ES; Park CI; Chang HC; Park CW; Lee DS
    Clin Rehabil; 2006 Aug; 20(8):668-74. PubMed ID: 16944824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of botulinum toxin in treatment of spasticity and functional improvements for children suffering from cerebral palsy.
    Meholjic A; Madjar D
    Med Arh; 2010; 64(6):359-61. PubMed ID: 21218755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
    Williams SA; Reid S; Elliott C; Shipman P; Valentine J
    Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.